The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry.
about
Ebola virus diseaseEbola virus disease and critical illness.Addressing Therapeutic Options for Ebola Virus Infection in Current and Future OutbreaksEbola: translational science considerationsVirtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infectionEbola virus: A gap in drug design and discovery - experimental and computational perspective.Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials.Anti-Ebola therapies based on monoclonal antibodies: current state and challenges ahead.A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity.Potential clinical treatment for Ebola pandemic.Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus.Small molecules with antiviral activity against the Ebola virusEbola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment.Molecular mechanisms of Ebola virus pathogenesis: focus on cell death.Ebola hemorrhagic fever: current outbreak and progress in finding a cure.Primary biliary acids inhibit hepatitis D virus (HDV) entry into human hepatoma cells expressing the sodium-taurocholate cotransporting polypeptide (NTCP).Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs.Ebola virus disease: what canadian hospital pharmacists need to knowChemical and Structural Aspects of Ebola Virus Entry Inhibitors.Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry.Possible FDA-approved drugs to treat Ebola virus infectionMachine learning models identify molecules active against the Ebola virus in vitroEbola Virus Infection: Overview and Update on Prevention and Treatment.Investigation of Calcium Channel Blockers as Antiprotozoal Agents and Their Interference in the Metabolism of Leishmania (L.) infantum.Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV).Modulation of HCV reinfection after orthotopic liver transplantation by fibroblast growth factor-2 and other non-interferon mediators.Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entryPotential and emerging treatment options for Ebola virus disease.Ebola virus outbreak, updates on current therapeutic strategies.Development of experimental and early investigational drugs for the treatment of Ebola virus infections.Development of Small-Molecule Antivirals for Ebola.Ebola virus entry into host cells: identifying therapeutic strategies.Amiodarone and metabolite MDEA inhibit Ebola virus infection by interfering with the viral entry process.Op GRITROCK ethics; the way of things to come?Therapeutics for postexposure treatment of Ebola virus infection.FDA approved drugs as potential Ebola treatments.Antiviral activity of cationic amphiphilic drugs.Discovering Drugs for the Treatment of Ebola Virus.Repurposed Therapeutic Agents Targeting the Ebola Virus: A Systematic Review.Updates on Treatment of Ebola Virus Disease.
P2860
Q24563097-10495168-BC52-479A-9D79-A60F36D6AFA4Q26250274-663F428B-6862-4737-9BF2-DA1F6BA8253FQ26801423-928AF3F9-4B2B-4261-BC59-B2E2740708C5Q28082994-961DFBED-FFDE-4770-97BF-BE6E0C6A31C6Q28649882-C197D1BE-7F84-4384-86EE-AEE47E2E98C6Q30243938-6FE9FC05-7BF3-44A9-9FEE-ED165818FF93Q30251949-FF54ABF6-57D8-403D-AD9C-66C7F3414D8EQ30252022-39895663-83DF-4AA0-9563-CD60168A3399Q30279239-11C3B43B-C3A2-4851-8184-CE48941105B6Q30366997-95C71A20-6010-48C9-BB24-5573387ED469Q34463780-33DFA1DA-5750-4E46-9255-A7537935EE8CQ34464403-2A9A11C1-6F18-4DB4-B85E-2C9476D1E630Q34464824-17991807-492D-416D-95FF-1D8246EE9AF8Q34478514-37306795-7971-41A3-B2DB-84CF628DD957Q34491250-A73CCBB3-F53D-40CC-B8C4-7C68C2B8903EQ35043978-F4302E7B-96D3-4977-8CFB-9A0ACC65E72AQ35050840-D451D368-A0DB-47C2-9DEA-09130B49CA2BQ35551653-3FCB59D0-4885-4BF4-8E66-588F00BFF42FQ35589926-F0A17EE9-ED00-47C6-B76F-B7D9FE53E3C9Q35605579-51D3B826-F512-4800-94D8-5782888B2D1BQ35609603-5820D702-064E-4C94-A0AC-A50F74B279BEQ35911643-0D334976-F814-46FA-974A-FFEFF006D923Q36363253-0784991F-B6C3-480B-929C-B6DD277DC274Q36569124-51930EEC-D378-4B9F-9897-C5272F606000Q36884852-8ABBA2CF-69C4-481C-A889-EA1AAEAC1DB3Q36968841-38D63485-9FDD-4E96-B413-6304A62E0DF4Q37224249-221F6897-9AFB-4701-B786-1EBD66D6B08CQ38270149-5EAB9FCF-1734-44E8-A743-F5A37F5EA502Q38473251-3EF14BA4-7E45-45EF-981D-EDC63A6E4F12Q38524949-9319516A-BAF2-496B-97D3-98B7B4E3D404Q38546746-13871B09-A0B2-435E-8590-F0BA7A6886E3Q38618148-8DE6D8DF-B539-4E87-82E2-FF1E72F69C3FQ38880125-08847463-5AF4-45ED-A378-3CBC143C57A1Q38890967-F238843A-B1B0-4AAB-9C41-A31B4FD87805Q38980947-F229AE4A-CBF3-4455-A540-D09F996704AAQ39027505-AF9CC2D5-CAE2-4715-BF0D-3BB430C3C706Q39175768-EA54F9EB-F40D-4464-BC62-1985C7A548AAQ40039706-F12A7B4F-D1ED-4D02-B613-000016915AACQ40045378-175DF23E-25FA-455C-93BE-37140E246F0FQ40133255-F4FA3FD7-8433-429C-A889-02B1F332DD2D
P2860
The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The clinically approved drugs ...... inhibit filovirus cell entry.
@ast
The clinically approved drugs ...... inhibit filovirus cell entry.
@en
The clinically approved drugs ...... inhibit filovirus cell entry.
@nl
type
label
The clinically approved drugs ...... inhibit filovirus cell entry.
@ast
The clinically approved drugs ...... inhibit filovirus cell entry.
@en
The clinically approved drugs ...... inhibit filovirus cell entry.
@nl
prefLabel
The clinically approved drugs ...... inhibit filovirus cell entry.
@ast
The clinically approved drugs ...... inhibit filovirus cell entry.
@en
The clinically approved drugs ...... inhibit filovirus cell entry.
@nl
P2093
P2860
P356
P1476
The clinically approved drugs ...... inhibit filovirus cell entry.
@en
P2093
Eva Mittler
Florian W R Vondran
Franziska Dahlmann
Gerrit Gehring
Katrin Rohrmann
Michael P Manns
Nkacheh Atenchong
Sandra Ciesek
Sascha David
Thomas von Hahn
P2860
P304
P356
10.1093/JAC/DKU091
P407
P577
2014-04-07T00:00:00Z